Charlotte's Web responds to new regulatory developments in California
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 24 2024
0mins
Should l Buy ?
Charlotte's Web's Opposition to Regulations: Charlotte's Web opposes new California regulations that restrict the sale of ingestible full-spectrum hemp CBD products, arguing they unfairly include non-intoxicating products in a regulatory framework meant for synthetic and intoxicating items.
Collaborative Efforts for Consumer Access: The company is working with industry and consumer advocacy groups to advocate for changes that preserve access to hemp-derived wellness products, while noting that the regulations will not significantly impact their overall sales in 2024.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
